Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy

Surgery

Volumn 126, Issue 6, 1999, Pages 1049-1055

  Nilsson, Inga Lena ^a,b   Åberg, Jan ^a,b   Rastad, Jonas ^a,b   Lind, Lars ^a,b  

^a SUNDSVALL HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGED; ARTERY ENDOTHELIUM; ARTICLE; BODY PLETHYSMOGRAPHY; CAROTID ARTERY; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; VASODILATATION;

EID: 0032733286     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2099.101422     Document Type: Article

References (25)

1. 1. Hedbäck G, Odén A, Tisell L-E. The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 1991;15:399-407.
2. 2. Palmér M, Adami H-O, Bergström R, Jacobsson S, Åkerström G, Ljunghall S. Survival and renal function in untreated hypercalcemia: population-based cohort study with 14 years of follow up. Lancet 1987;1:59-62.
3. 3. Lundgren E, Szabo E, Ljunghall S, Bergström R, Holmberg L, Rastad J. Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism. Br Med J 1998;317:848-51.
4. 4. Ljunghall S, Joborn C, Palmér M, Rastad J, Åkerström G. Primary hyperparathyroidism: the surgically cured patient. In: Kleerekoper M, Krane SM, editors. Clinical disorders of bone and mineral metabolism. New York: Mary Ann Liebert; 1989. p. 353-8.
5. 5. Sancho JJ, Rouco J, Riera-Vidal R, Sitges-Serra A. Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension. World J Surg 1992;16:732-6.
6. 6. Pang PK, Benishin CG, Lewanczuk RZ. Parathyroid hypertensive factor, a circulating factor in animal and human hypertension. Am J Hypertens 1991;4:472-7.
7. 7. Schlüter H, Quante C, Buchholz B, et al. A vasopressor factor partially purified from human parathyroid glands. Biochem Biophys Res Commun 1992;1188:323-9.
8. 8. Mc Carron DA, Morris CD, Bukoski R. The calcium paradox of essential hypertension. Am J Med 1987;82:27-33.
9. 9. Hulter HN, Melby JC, Peterson JC, Cooke CR. Chronic continous PTH infusion results in hypertension in normal subjects. J Clin Hypertens 1986;2:360-70.
10. 10. Jiang B, Morimoto S, Yang J, Niinoabu T, Fukuo K, Ogihara T. Expression of parathyroid hormone/parathyroid hormone-related protein receptor in vascular endothelial cells. J Cardiovasc Pharmacol 1998;31 (suppl 1):142-4.
11. 11. Vane JR, Ānggård EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
12. 12. Panza JA, Arshed A, Quyyumi A, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
13. 13. Adams MR, Robinson J, Mc Credie R, et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998;32:123-7.
14. 14. Ghiadoni L, Taddei S, Virdis A, et al. Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension 1998;32:25-32.
15. 15. Millgård J, Lind L. Divergent effects of different antihypertensive drugs on endothelium-dependent vasodilatation in the human forearm. J Cardiovasc Pharmacol 1998;32:406-12.
16. 16. Lind L, Sarabi M, Millgard J. Methodological aspects of the evaluation of endothelium-dependenl vasodilation in the human forearm. Clin Physiol 1998;18:81-7.
17. 17. NIH Consensus Development Conference Statement. J Bone Miner Res 1991;6(suppl 2):S9-13.
18. 18. Kleerekoper M, Bilezikian JP. A cure in search of a disease: parathyroidectomy for nontraditional features of primary hyperparathyroidism. Am J Med 1994;96:99-100.
19. 19. Söreide JA, van Heerden JA, Grant CS, Yau Lo C, Schleck C, Ilstrup DM. Survival after surgical treatment for primary hyperparathyroidism. Surgery 1997;122:1117-23.
20. 20. Hedbäck G, Odén A. Increased risk of death from primary hyperparathyroidism: an update. Eur J Clin Invest 1998;28:271-6.
21. 21. Stefenelli T, Abela C, Frank H, Koller-Strametz J, Niederle B. Time course of regression of left ventricular hypertrophy after successful parathyroidectomy. Surgery 1997;121:157-61.
22. 22. Lundgren E, Rastad J, Thurfjell E, Åkerström G, Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997;121:287-94.
23. 23. Neunteufl T, Katzenschlager R, Abela C, Kostner K, Niederle B, Weidinger F, Stefenelli T. Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res 1998;40:396-401.
24. 24. Millgård J, Lind L. Acute hypertension impairs endothelium-dependent vasodilation. Clin Sci 1998;94:601-7.
25. 25. Hurwitz L, Mc Guffe LJ, Smith PM, Little SA. Specific inhibition of calcium channels by calcium ions in smooth muscle. J Pharmacol Exp Ther 1982;220:382-8.